TMH home




Home Health Centers For Healthcare Professionals Patient and Visitor Guide Press Room Find a Physician
 
 

About Us
Pay Your Bill Online
myTMH Patient Portal
Press Room
Career Center
Patient and Visitor Guide
Online Registration
Classes and Events
Support Groups
Access Our Health Library
Web Nursery
Ways To Give
Community Needs Health Assessment
Contact Us

Cancer Center

 
Tallahassee Memorial Cancer Center Clinical Trials
Hematology

1. Genetics of Thrombotic Storm -characterize patients with ‘thrombotic storm’ (TS) syndromes (including patients with catastrophic antiphospholipid antibody syndrome), track the subsequent clinical course of patients with these disorders over time, use detailed family history information to identify any potentially inherited patterns for thrombotic complications or autoimmune disorders in the families of these patients


Prostate Cancer

2. RTOG 0534 A Phase III Trial of Short Term Androgen Deprivations With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy


Melanoma

3. ECOG 1609 (Pending approval) - A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma.


Breast Cancer

4. CALGB 70305 - Randomized Study of Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I-III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection.

5. SWOG 1105 - Text-Messaging in Reducing Early Discontinuation of Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer Who Underwent Breast Surgery


Lung Cancer

6. RTOG 0813 – Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients

7. LBM001 (Pending Approval) – A Phase II Double Blind Randomized Trial Comparing Standard Dosing Based on Body Surface Area versus Dosing Based on Personalized lean Body Mass in Patients with Stage IIIB or IV Non-Small Cell Lung Cancer Receiving First Line Cisplatin Based Chemotherapy


For more information on clinical trials please contact:

Clinical Research Department
Theresa Shannon or Julie Campbell
Phone: (850) 431-5566/5424
Email: Theresa.Shannon@tmh.org or Julie.campbell@tmh.org